Veterinary Medicine Information website

CEVAC VITABRON L

Authorised
  • Newcastle disease virus, strain PHY.LMV.42, Live
  • Infectious bronchitis virus, type Massachusetts, strain H120, Live
Download as PDF

Product identification

Medicine name:
CEVAC VITABRON L
Active substance:
  • Newcastle disease virus, strain PHY.LMV.42, Live
  • Infectious bronchitis virus, type Massachusetts, strain H120, Live
Target species:
  • Chicken (chick)
Route of administration:
  • Ocular use
  • Nebulisation use

Product details

Active substance and strength:
  • Newcastle disease virus, strain PHY.LMV.42, Live
    5.50
    log 10 50% embryo infective dose
    /
    1.00
    Dose
  • Infectious bronchitis virus, type Massachusetts, strain H120, Live
    3.30
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2206
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 28/09/2023
Updated on: 30/09/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 20/10/2025
Download